Bibliography
- Woodrow KA, Bennett KM, Lo DD. Mucosal vaccine design and delivery. Annu Rev Biomed Eng 2012;14:17-46
- Asanuma H, Aizawa C, Kurata T, Tamura S. IgA antibody-forming cell responses in the nasal-associated lymphoid tissue of mice vaccinated by intranasal, intravenous and/or subcutaneous administration. Vaccine 1998;16:1257-62
- Craig SW, Cebra JJ. Peyer's patches: an enriched source of precursors for IgA-producing immunocytes in the rabbit. J. Exp Med 1971;134:188-200
- Wu HY, Nguyen HH, Russell MW. Nasal lymphoid tissue (NALT) as a mucosal immune inductive site. Scand J Immunol 1997;46:506-13
- Shikina T, Hiroi T, Iwatani K, IgA class switch occurs in the organized nasopharynx- and gut-associated lymphoid tissue, but not in the diffuse lamina propria of airways and gut. J Immunol 2004;172:6259-64
- Neutra MR, Frey A, Kraehenbuhl JP. Epithelial M cells: gateways for mucosal infection and immunization. Cell 1996;86:345-8
- Neutra MR, Kozlowski PA. Mucosal vaccines: the promise and the challenge. Nat Rev Immunol 2006;6:148-58
- Clark MA, Hirst BH, Jepson MA. M-cell surface beta1 integrin expression and invasin-mediated targeting of Yersinia pseudotuberculosis to mouse Peyer's patch M cells. Infect Immun 1998;66:1237-43
- Fotopoulos G, Harari A, Michetti P, Transepithelial transport of HIV-1 by M cells is receptor-mediated. Proc Natl Acad Sci USA 2002;99:9410-14
- Hase K, Kawano K, Nochi T, Uptake through glycoprotein 2 of FimH(+) bacteria by M cells initiates mucosal immune response. Nature 2009;462:226-30
- Jensen VB, Harty JT, Jones BD. Interactions of the invasive pathogens Salmonella typhimurium, Listeria monocytogenes, and Shigella flexneri with M cells and murine Peyer's patches. Infect Immun 1998;66:3758-66
- Martinoli C, Chiavelli A, Rescigno M. Entry route of Salmonella typhimurium directs the type of induced immune response. Immunity 2007;27:975-84
- Nakato G, Hase K, Suzuki M, Cutting edge: Brucella abortus exploits a cellular prion protein on intestinal M cells as an invasive receptor. J Immunol 2012;189:1540-4
- Wolf JL, Rubin DH, Finberg R, Intestinal M cells: a pathway for entry of reovirus into the host. Science 1981;212:471-2
- Glomski IJ, Piris-Gimenez A, Huerre M, Primary involvement of pharynx and peyer's patch in inhalational and intestinal anthrax. PLoS Pathog 2007;3:e76
- Garinot M, Fiévez V, Pourcelle V, Gylated PLGA-based nanoparticles targeting M cells for oral vaccination. J Control Release 2007;120:195-204
- Nochi T, Yuki Y, Matsumura A, A novel M cell-specific carbohydrate-targeted mucosal vaccine effectively induces antigen-specific immune responses. J Exp Med 2007;204:2789-96
- Rynda A, Maddaloni M, Mierzejewska D, Low-dose tolerance is mediated by the microfold cell ligand, reovirus protein sigma1. J Immunol 2008;180:5187-200
- Suzuki H, Sekine S, Kataoka K, Ovalbumin-protein sigma 1 M-cell targeting facilitates oral tolerance with reduction of antigen-specific CD4+ T cells. Gastroenterology 2008;135:917-25
- Wang X, Kochetkova I, Haddad A, Transgene vaccination using Ulex europaeus agglutinin I (UEA-I) for targeted mucosal immunization against HIV-1 envelope. Vaccine 2005;23:3836-42
- Wu Y, Wang X, Csencsits KL, M cell-targeted DNA vaccination. Proc Natl Acad Sci USA 2001;98:9318-23
- Rajapaksa TE, Stover-Hamer M, Fernandez X, Claudin 4-targeted protein incorporated into PLGA nanoparticles can mediate M cell targeted delivery. J Control Release 2010;142:196-205
- Rajapaksa TE, Bennett KM, Hamer M, Intranasal M cell uptake of nanoparticles is independently influenced by targeting ligands and buffer ionic strength. J Biol Chem 2010;285:23739-46
- Lo DD, Ling J, Eckelhoefer AH. M cell targeting by a Claudin 4 targeting peptide can enhance mucosal IgA responses. BMC Biotechnol 2012;12:7
- Frey A, Giannasca KT, Weltzin R, Role of the glycocalyx in regulating access of microparticles to apical plasma membranes of intestinal epithelial cells: implications for microbial attachment and oral vaccine targeting. J Exp Med 1996;184:1045-59
- Lai SK, O'Hanlon DE, Harrold S, Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus. Proc Natl Acad Sci USA 2007;104:1482-7
- Lai SK, Wang Y-Y, Hida K, Nanoparticles reveal that human cervicovaginal mucus is riddled with pores larger than viruses. Proc Natl Acad Sci USA 2010;107:598-603
- Shakweh M, Ponchel G, Fattal E. Particle uptake by Peyer's patches: a pathway for drug and vaccine delivery. Expert Opin Drug Deliv 2004;1:141-63
- Shakweh M, Besnard M, Nicolas V, Fattal E. Poly (lactide-co-glycolide) particles of different physicochemical properties and their uptake by peyer's patches in mice. Eur J Pharm Biopharm 2005;61:1-13